Panbela Therapeutics Propriété du management
Quel est le Propriété du management de Panbela Therapeutics?
Le Propriété du management de Panbela Therapeutics Inc. est 14.55%
Quelle est la définition de Propriété du management?
La propriété d'un initié est calculée en divisant le nombre total d'actions possédées par des initiés (actionnaires détenant plus de 5% de la société ou un dirigeant ou un administrateur de la société) par le nombre total d'actions en circulation.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Propriété du management des entreprises dans Health Care secteur sur NASDAQ par rapport à Panbela Therapeutics
Que fait Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Entreprises avec propriété du management similaire à Panbela Therapeutics
- Rimini Street a Propriété du management de 14.50%
- Casper Sleep Inc a Propriété du management de 14.50%
- Xali Gold Corp a Propriété du management de 14.50%
- Terra Tech a Propriété du management de 14.52%
- Sylla Gold Corp a Propriété du management de 14.52%
- Baron Oil Plc a Propriété du management de 14.53%
- Panbela Therapeutics a Propriété du management de 14.55%
- Allied Healthcare Product a Propriété du management de 14.55%
- Vikas WSP a Propriété du management de 14.56%
- United (Martins Ferry, OH) a Propriété du management de 14.58%
- Greenstone Capital a Propriété du management de 14.59%
- Longboat plc a Propriété du management de 14.59%
- United Security Bancshares (CA) a Propriété du management de 14.59%